Yayınları
x
2. BÝLÝMSEL ÇALIÞMALAR:
2.1. Doktora veya Ýhtisas Tezi:
Mide Kanseri için yeni peri adjuvan tedavi stratejileri.
Tez Danýþmaný: Prof. Dr. Howard Bruckner, Mount Sinai Týp Fakültesi
Ýleri safha pankreas kanserinde kombine tedavi uygulamasý ve uzun dönemli takibi.
Tez Danýþmaný: Prof. Dr. Howard Bruckner, Mount Sinai Týp Fakültesi
2.2. Doktora veya ihtisas tezinden yayýnlanmýþ makaleler:
A. DOÇENTLÝK ÖNCESÝ
2.2.1. Turhal NS, Bruckner HW. “New neoadjuvant treatment strategies for gastric and
gastroesophageal junction cancers”, Marmara Medical Journal 1999 12(1): 20-24.
2.2.2. Turhal NS, Terk M, Bruckner HW. “Combined Modality Therapy for Pancreatic
Cancer”. Turkish Journal of Cancer, 1999 11(2): 55-64.
2.3. Doktora veya ihtisas tezi dýþýnda yayýnlanmýþ makaleler:
2.3.1. Uluslararasý hakemli dergilerde yayýmlanan makaleler :
A. DOÇENTLÝK ÖNCESÝ
2.3.1.1. Turhal N, Sullivan MB, Blakemore WS. Thyroglossal Duct Cyst. South Med J,
1990, 83:8, 983-4.
Atýflar: 2 adet
2.3.1.2. Turhal N, DeLuca VA Jr. Ulcerative Colitis and Scleroderma. A coincidental
relationship. J Clin Gastroenterol. 1994, 18:3, 218-9.
Atýflar: 1 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=14087877503050283226
2.3.1.3. Turhal NS, Henehan MD, Kaplan KL. Multiple myeloma: a patient with unusual
features including intracranial and meningeal involvement, testicular involvement,
organomegaly, and plasma cell leukemia. Am J Hematol 1998, 57:1, 51-56.
Atýflar: 5 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=16038244302575248353
2.3.1.4. Turhal NS. Cyclosporin A and Imipenem Associated Seizure Activity in
Allogeneic Bone Marrow Transplantation Patients. Journal of Chemotherapy 1999 11(5):
410-413.
Atýflar: 1 adet
B. DOÇENTLÝK SONRASI
2.3.1.5. Turhal NS, Erdal S, Karacay S. Efficacy of the Treatment to Relieve Mucositis
Induced Discomfort. Supportive Care in Cancer 2000 8(1): 55-58.
Atýflar: 11 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=9224762740491128396
2.3.1.6. Turhal NS. Pancreatic Duct Cell Carcinoma with Positive In-111 Octreotide
Uptake. Journal of Experimental and Clinical Cancer Research 2000 19(2): 241-244.
Atýflar: 1 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3086857171421125646
2.3.1.7. Turhal NS. Sumatriptan overdose in episodic cluster headache: a case report of
overuse without event. Cephalalgia. 2001 21:700.
Atýflar: 2 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3305478064832093771
2.3.1.8. Turhal NS, Rand J. Antiphospholipid syndrome in HIV infection - Report of four
cases and review of literature. Allergy & Clinical Immunology International 2001 13(6):1-
4.
Atýflar: 4 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=7397992836540309533
2.3.1.9. Duman D, Turhal NS, Duman DG, M.D. Fatal Aplastic Anemia during Treatment
with Ketoconazole. American Journal of Medicine 2001, 111:9
Atýflar: 2 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3117564245376579991
2.3.1.10. Turhal NS. Two cases of advanced renal cell cancer with prolonged survival of
8 and 12 years. Japanese Journal of Clinical Oncology 2002 32(4): 152-153
Atýflar: 1 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=13935624351722493486
2.3.1.11. Turhal NS, Gumus M, Atalay G, Aliustaoglu M, Kabakas F, Karamanoglu A,
Sengoz M. Outpatient cancer care in a Turkish university hospital. Journal of BUON 2002
7(4): 397-398.
2.3.1.12. Turhal NS, Efe B, Gumus M, Aliustaoglu M, Karamanoglu A, Sengoz M. Patient
satisfaction in the outpatients’ chemotherapy unit of Marmara University, Istanbul,
Turkey: a staff survey. BMC Cancer 2002 2(1): 30-33.
Atýflar: 1 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10755444610255035949
2.3.1.13. Turhal NS, Aliustaoglu M, Gurses I, Gumus M, Atalay G, Karamanoglu A,
Sengoz M. Neoplastic diseases prevalence in a Turkish university hospital. Journal of
BUON 2003 8(1): 45-48.
2.3.1.14. Karamanoglu A, Yumuk PF, Gumus M, Aliustaoglu M, Selimen D, Sengoz M,
Turhal NS. Port needles: Do they need to be removed as frequently in infusional
chemotherapy? Journal of Infusional Nursing 2003 26(4):239-242
Atýflar: 3 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3285498604753279414
2.3.1.15. Abacýoglu U, Sengoz M, Yumuk F, Salepci T, Turhal NS. Cisplatin and
etoposide in extra pulmonary small cell cancer. Tumori 2003 89(3): 274-277.
Atýflar: 20 adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=12670133082976671960
2.3.1.16. Yumuk PF, Abacioglu U, Caglar H, Gumus M, Sengoz M, Turhal NS. Outcome
of rectum and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in
Marmara University Hospital. J Chemother 15 (6): 603-606, 2003.
2.3.1.17. Turhal NS, Dane F, Dede F, Gumus M, Yumuk PF, Cakalagaoglu F, Savcý D,
Karaman M, Gulluoglu B, Turoglu HT. 99m-Tc-MDP Scintimammography to assess
angiogenesis in patients with untreated breast cancer. Anticancer Research. 24:1999-
2006 (2004)
Atýflar: 1 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=8066682829616811384
2.3.1.18. Yumuk PF, Gumus M, Ekenel M, Basaran G, Aliustaoglu M, Topal A, Turhal
NS, N. Attitude Toward Genetic Testing in Turkish Society. Genetic Testing 8(2):169-173,
2004
Atýflar: 2 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=12681732269582698398
2.3.1.19. Yumuk PF, Aydin SZ, Dane F, Gumus M, Ekenel M, Aliustaoglu M,
Karamanoglu A, Sengoz M, Turhal NS. The absence of early diarrhea with atropine
premedication during irinotecan therapy in metastatic colorectal patients. International
Journal of Colorectal Disease 19: 609-610, 2004.
2.3.1.20. Bolukbas FF, Kýlýc H, Bolukbas C, Gumus M, Horoz M, Turhal NS, Kavalý B.
Serum leptin concentration and advanced gastrointestinal cancers: a case controlled
study. BMC Cancer 2004, 4:29-32.
Atýflar: 7 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=17826764500982860129
2.3.1.21. Yumuk PF, Abacioglu U, Demir G, Cabuk D, Dane F, Gumus M, Ozguroglu M,
Ekenel M, Basaran G, Turhal NS. Does the Incidence of Anal Canal Cancers Differ in
Moslem Societies? International Journal of Colorectal Disease, Clinical and Molecular
Gastroenterology and Surgery. 10.1007/s00384-004-0614-4. 2004.
2.3.1.22. Aliustaoglu M, Yumuk PF,Gumus M, Ekenel M, Bolukbas F, Mutlu N, Basaran
G, Avsar E, Turhal NS. D-Dimer—Can it be a marker for malignant gastric lesions. Acta
Oncologica, 2004 Dec 43(8) 770-771.
Atýflar: 2 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10828204231987902171
2.3.1.23. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J,
Koller M, Turhal NS, Stuart R, Van Cutsem E, D’Haese S, Coens C. Clinical and
Psychometric validation of a questionnaire module, The EORTC QLQ-STO 22, to assess
quality of life in patients with gastric cancer. Eur J Cancer, 2004 Oct 40(15): 2260-8
Atýflar: 13 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=7446152185685022904
2.3.1.24. Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F, Caglar
H, Sengoz M, Turhal S. What should be the optimal number of lymph nodes dissected in
colorectal Cancer surgery? Tumori, 172/03. 11 2004.
PROFESÖRLÜK SONRASI
2.3.1.25. Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, Salepci T,
Aliustaoglu M, Ahiskali R, “Results of paclitaxel (day 1 and 8) and Carboplatin given on
every three weeks in advanced (stage III-IV) non-small cell lung Cancer”, BMC Cancer,
(MS:7372801141679098), 2005 March, 21
2.3.1.26. Abacioðlu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS, “Concurrent
chemoradiotherapy with low dose weekly Gemcitabine in stage III non-small cell lung
cancer.” BMC Cancer. 2005 Jul, 6;5:71
Atýflar: 3 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=4020091328951835599
2.3.1.27. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. “Proximal
type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs
immediate attention.” Eur Urol. 2006 Feb; 49(2):7. Epub 2005 Nov 7.
Atýflar: 2 Adet
http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=5503029184430428787
2.3.1.28. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. “Proximal
type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs
immediate attention: Part 2.” Eur Urol 2006 Mar 49(3):578-80.
2.3.1.29 Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G,
Kaya H, Barisik N, Turhal NS. “HPV DNA frequency and subset analysis in human
breast cancer patients normal and tumoral tissue samples.” J Exp Clin Cancer Res. 2006
Dec;25(4):515-21.
2.3.1.30 Komurcu S, Turhal NS, Altundag K, Atahan L, Turna HS, Manavoglu O, Yavuz
AA, Ozkok S, Aliustaoglu M, Altinbas M, Pak Y, Cooper R, Yaylaci M, Demirkan B,
Sarihan S, Ozdemir F. “Safety and efficacy of transdermal fentanyl in patients with cancer
pain: phase IV, Turkish Oncology group trial.” Eur J Cancer Care (Engl). 2007 Jan;
16(1):67-73
2.3.1.31. Turhal NS, Popov IP. “Colorectal cancer care in the Balkan countries.” J BUON
2005 Apr-Jun;10(2):189-93
2.3.1.32. Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z,
Mayadagli A, Basaran G, Turhal NS, Sengoz M. “Concomitant administration of uraciltegafur
and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.” J
BUON. 2007 Apr-Jun;12(2):203-8.
2.3.1.33. Celikel C, Eren F, Gulluoglu B, Bekiroglu N, Turhal NS. “Relation of
neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor
receptor expression in gastric adenocarcinomas: prognostic implications.” Pathol Oncol
Res. 2007:13(3):215-26. Epub 2007 Oct 7.
2.3.1.34. Cabuk D, Basaran G, Celikel C, Dane F, Yumuk PF, Iyikesici MS, Ekenel M,
Turhal NS. “Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and
CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors
and Prognostic Impact on Survival.” Oncology. 2007 Nov 15;72(1-2):111-117.
2.3.2. Ulusal hakemli dergilerde yayýmlanan makaleler :
A. DOÇENTLÝK ÖNCESÝ
2.3.2.1. Turhal NS. “Metastatik meme kanseri yaygýn kemik metastazlarýnda tedavi”,
Kanser Gündemi, Türkiye Kanserle Savaþ Vakfý, 1998 3(3): 118-121.
2.3.2.2. Turhal NS. “Yetiþkin kanser hastalarýnda transfüzyon tedavisi yaklaþýmlarý”
Damla, Kan Merkezleri ve Transfüzyon Derneði Bülteni, 1998 22:4-7.
2.3.2.3. Turhal NS. “Meme kanserinin biyolojik tedavisinde: Herceptin, Academic
Hospital 1998 4:16-18.
2.3.2.4. Turhal NS, Tanju P, Pekin S. “Serviks kanseri etyolojisine yönelik standart ve
gelecek vadeden tarama yaklaþýmlarý” Hekimler Birliði Vakfý, Türkiye Klinikleri,
Jinekolojik Obstetrik, 1999 9(3): 215-220.
2.3.2.5. Turhal NS, Akdas A. “Prostat kanserinde gen tedavisi uygulamasý ve sorunlarý”
Üroloji Bülteni 1999 10(1): 5-11.
